Here we show that high YAP expression suggests poor prognosis for glioma patients with radiotherapy and radiation activates YAP, which contributes to glioma progression after radiation via driving the expression of fibroblast growth factor 2 (FGF2) and subsequently activating the mitogen-activated protein kinase (MAPK) pathway. The gene discussed is WNK2; the disease is glioma.